Professional & Business

  • International Medical Press

PHE campaign targets antibiotic prescribing

  • International Medical Press

Ministers scrap data collection on NHS staff assaults

  • International Medical Press

Overseas visitors policy threat to all, say experts

  • International Medical Press

Prioritize child health in policy-making, says RCPCH

  • International Medical Press

GP referrals reduce diabetes risk in third of patients

  • International Medical Press

England to ban ‘supersized’ chocolate bars in hospitals

View more

New in Gastroenterology

Don't wait until HCV becomes chronic to treat with DAAs | AASLD
  • RSi Communications
  • 1 comment

Don't wait until HCV becomes chronic to treat with DAAs | AASLD

Treating acute vs chronic HCV increased QALYs and decreased costs.

Women more likely to have anti-TB DILI | AASLD
  • Conference reports - RSi Communications
  • 1 comment

Women more likely to have anti-TB DILI | AASLD

Hepatotoxicity may be increased in women despite TB being less common.

Liver Disease: Monthly Essentials October 2017
  • Global Monthly Essentials
  • 1 comment

Liver Disease: Monthly Essentials October 2017

HCV survival benefit with DAA | Shorter course GLE/PIB effective with some genotypes | Ravidasvir + SOF phase 3 results.

  • Global Clinical Summaries from Scand J Gastroenterol
  • no comment

Is IBD likelier after antibiotics? A systematic review

Hints of a link amid heterogeneous and flawed studies.

DAA agents allow transplantation of ‘high risk’ organs | AASLD
  • RSi Communications
  • 1 comment

DAA agents allow transplantation of ‘high risk’ organs | AASLD

25 anti-HCV- candidates received HCV-IRD organs; HCV disease transmission occurred in 4 (16%).

Many inpatients with PE and GH undergo endoscopy with low mortality | WCG
  • Conference reports - RSi Communications
  • 1 comment

Many inpatients with PE and GH undergo endoscopy with low mortality | WCG

Association between endoscopy and lower mortality persists when controlled for critical illness and condition upon admission.

No strategy predominates managing eosinophilic esophagitis | WCG
  • Conference reports - RSi Communications
  • 1 comment

No strategy predominates managing eosinophilic esophagitis | WCG

Patients maintained on a PPI were just as likely as those off PPI to remain symptomatic.

  • Global Clinical Summaries from Fam Pract
  • 1 comment

PPIs tied to 42% increased risk for CKD

Data from a Taiwanese population-based study.

ESMO announces winner of first award for immuno-oncology
  • Global Medical News
  • 1 comment

ESMO announces winner of first award for immuno-oncology

The ESMO Award for Immuno-Oncology was created this year in commemoration of the organisation’s first President, Prof Georges Mathé.

  • Global Clinical Summaries from Aliment Pharmacol Ther
  • 1 comment
  • FULLTEXT

Treating Crohn’s disease with golimumab

Retrospective analysis finds safety and efficacy.

Antimicrobials and antiepileptics leading causes of pediatric drug-induced liver injury | AASLD
  • Conference reports - RSi Communications
  • 1 comment

Antimicrobials and antiepileptics leading causes of pediatric drug-induced liver injury | AASLD

The top five implicated agents were minocycline, valproate, azithromycin, and isoniazid.

Junior doctors in Poland on hunger strike
  • Global Medical News
  • 1 comment

Junior doctors in Poland on hunger strike

A number of junior doctors in Poland have gone on hunger strike over poor pay and working conditions, and healthcare funding.

Charging overseas visitors for hospital care is dangerous - BMJ
  • UK Medical News
  • 1 comment

Charging overseas visitors for hospital care is dangerous - BMJ

From 23 October 2017, patients who are unable to establish their entitlement to free care, will be charged upfront for treatment.

Lactulose breath testing predicts response to rifaximin in patients with IBS-D | WCG
  • Conference reports - RSi Communications
  • 1 comment

Lactulose breath testing predicts response to rifaximin in patients with IBS-D | WCG

Response rate in patients whose breath test results normalized after rifaximin treatment was 76.5%.